1. Pancreatic lipase inhibitory activity of phenolic inhibitor from endophytic Diaporthe arengae
- Author
-
Shahid Mohammad, Bhushan S. Bhadane, Vijay L. Maheshwari, Mohini P. Patil, and Ravindra H. Patil
- Subjects
0301 basic medicine ,Specificity constant ,Bioengineering ,Diaporthe arengae ,Inhibitory postsynaptic potential ,Applied Microbiology and Biotechnology ,03 medical and health sciences ,0404 agricultural biotechnology ,medicine ,Pancreatic lipase ,Chromatography ,biology ,Drug candidate ,Chemistry ,04 agricultural and veterinary sciences ,Endophytic fungus ,040401 food science ,Orlistat ,030104 developmental biology ,Biochemistry ,biology.protein ,Fermentation ,Agronomy and Crop Science ,Food Science ,Biotechnology ,medicine.drug - Abstract
The present study evaluates porcine pancreatic lipase (PPL) inhibitory potential of a phenolic fraction from the fermentation extract of endophytic fungus D. arengae. In absence of inhibitor (phenolic fraction), the initial K m and V max of PPL were found to be 3.83±0.94 µM and 11.54±0.54 µmole/min, respectively. While, in its presence the K m app and V max app was recorded as 7.48 µM and 10.6 µmole/min, respectively and were comparable to those obtained with standard, orlistat. Increase in the K m app and no change in the V max app in the presence of inhibitor (phenolic fraction) resulted in decrease in the specificity constant ( K cat / K m ). The inhibition constant ( K i ) for the phenol-rich fraction was recorded as 13.47±5.01 µg/ml, compared to 10.65±3.81 µM obtained for Orlistat. Thus, the phenol-rich fraction from endophytic D. arengae is able to inhibit PPL competitively as like Orlistat and holds promise as the potential drug candidate.
- Published
- 2017
- Full Text
- View/download PDF